Role of Adenosine as a Modulator of Synaptic Activity in the Central Nervous System

Advances in Pharmacology

Volumn 39, Issue C, 1997, Pages 353-391

  Brundege, James M ^a   Dunwiddie, Thomas V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR;

ANIMAL; BRAIN; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; BRAIN; HUMANS; NEURONS; RECEPTORS, PURINERGIC P1; SYNAPTIC TRANSMISSION;

EID: 0030626421     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60076-9     Document Type: Article

References (211)

1. Abbracchio M.P., Brambilla R., Ceruti S., Kim H.O., von Lubitz D.K., Jacobson J.E.K.A., and Cattabeni F. G protein-dependent activation of phospholipase C by adenosine A, receptors in rat brain. Mol. Pharmacol. 48 (1995) 1038-1045
2. Andy R.J., and Kornfeld R. The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J. Biol. Cbem. 257 (1982) 7922-7925
3. Arch J.R., and Newsholme E.A. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem. J. 174 (1978) 965-977
4. Arch J.R., and Newsholme E.A. The control of the metabolism and the hormonal role of adenosine (review). Essays Biochem. 14 (1978) 82-123
5. Ballarin M., Fredholm B.B., Ambrosio S., and Mahy N. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: Inhibition of uptake and metabolism. Acta Physiol. Scand. 142 (1991) 97-103
6. Bender A.S., Wu P.H., and Phillis J.W. The characterization of [3H] adenosine uptake into rat cerebral cortical synaptosomes. J. Neurochem. 35 (1980) 629-640
7. Bender A.S., Wu P.H., and Phillis J.W. The rapid uptake and release of [3H]adenosine by rat cerebral cortical synaptosomes. J. Neurocbem. 36 (1981) 651-660
8. Bennett M.R., and Ho S. Probabilistic secretion of quanta from nerve terminals in avian ciliary ganglia modulated by adenosine. J. Physiol. (London) 440 (1991) 513-527
9. Bennett M.R., and Ho S. Adenosine modulation of potassium currents in preganglionic nerve terminals of avian ciliary ganglia. Neurosci. Lett. 137 (1992) 41-44
10. Berne R.M., Rubio R., and Curnish R.R. Release of adenosine from ischemic brain. Circ. Res. 35 (1974) 262-271
11. Berne R.M., Winn H.R., and Rubio R. The local regulation of cerebral blood flow (review). Prog. Cardiovasc. Dis. 24 (1981) 243-260
12. Birnstiel S., Gerber U., and Greene R.W. Adenosine-mediated synaptic inhibition: Partial blockade by barium does not prevent anti-epileptiform activity. Synapse 11 (1992) 191-196
13. Boissard C.G., and Gribkoff V.K. The effects of the adenosine reuptake inhibitor soluflazine on synaptic potentials and population hypoxic depolarizations in area CA1 of rat hippocampus in vitro. Neuropbarmacology 32 (1993) 149-155
14. Bonci A., and Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16 (1996) 631-639
15. Brown S.J., James S., Reddington M., and Richardson P.J. Both A1 and A2a purine receptors regulate striatal acetylcholine release. J. Neurochem. 55 (1990) 31-38
16. Brundege J.M., and Dunwiddie T.V. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J. Neurosci. 16 (1996) 5603-5612
17. Bruns R.F., Lu G.H., and Pugsley T.A. Characterization of the A2 adenosine receptor labeled by [3H]-NECA in rat striatal membranes. Mol. Pharmacol. 29 (1986) 331-346
18. Capogna M., Gahwiler B.H., and Thompson S.M. Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium and α-latrotoxin in the hippocampus. J. Neurophysiol. 75 (1996) 2017-2028
19. Cass W.A., and Zahniser N.R. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. J. Neurochem. 57 (1991) 147-152
20. Ceballos G., Tuttle J.B., and Rubio R. Differential distribution of purine metabolizing enzymes between glia and neurons. J. Neurochem. 62 (1994) 1144-1153
21. Centelles J.J., Franco R., Canela E.I., and Bozal J. Kinetics of the 5′-nucleotidase and the adenosine deaminase in subcellular fraction of rat brain. Neurochem. Res. 11 (1986) 471-479
22. Chen Y., Graham D.I., and Stone T.W. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmacol. 106 (1992) 632-638
23. Craig C.G., and White T.D. NMDA and Non-NMDA evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release. J. Neurochem. 60 (1993) 1073-1080
24. Craig C.G., Temple S.D., and White T.D. Is cyclic AMP involved in excitatory amino acid-evoked adenosine release from rat cortical slices. Eur. J. Pharmacol. 269 (1994) 79-85
25. Cunha R.A., Johansson B., Constantino M.D., Sebastiao A.M., and Fredholm B.B. Evidence for high affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 353 (1996) 261-271
26. Daly J.W., Butts-Lamb P., and Padgett W. Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 3 (1983) 69-80
27. Da Prada M., and Pletscher A. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: Physiological properties and drug-induced changes. Br. J. Pharmacol. 34 (1968) 591-597
28. Daval J.L., and Barberis C. Release of radiolabelled adenosine derivatives from superfused synaptosome beds. Biochem. Pharmacol. 30 (1981) 2559-2567
29. Davies L.P., and Cook A.F. Inhibition of adenosine kinase and adenosine uptake in guinea-pig CNS tissue by halogenated tubercidin analogues. Life Sci. 56 (1995) PL345-PL349
30. Deckert J., and Jorgensen M.B. Evidence for pre- and postsynaptic localization of adenosine A1 receptors in the CA1 region of the rat hippocampus: A quantitative autoradiographic study. Brain Res. 446 (1988) 161-164
31. Delaney S.M., and Geiger J.D. Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum. Brain Res. 702 (1995) 72-76
32. Deussen A., Lloyd H.G., and Schrader J. Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J. Mol. Cell. Cardiol. 21 (1989) 773-782
33. Dolphin A.C., and Archer E.R. An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of gluramate but not GABA from slices of rat dentate gyrus. Neurosci. Lett. 43 (1983) 49-54
34. Dolphin A.C., Forda S.R., and Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue. J. Physiol. (London) 373 (1986) 47-61
35. Dragunow M. Purinergic mechanisms in epilepsy (review). Prog. Neurobiol. 31 (1988) 85-108
36. Dragunow M., and Faull R.L. Neuroprotective effects of adenosine. Trends Pharmacol. Sci. 9 (1988) 193-194
37. Drury A.N., and Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. (London) 68 (1929) 213-237
38. Duner-Engström M., and Fredholm B.B. Evidence that prejunctional adenosine receptors regulating acetylcholine release from rat hippocampal slices are linked to an N-ethylmaleimide-sensitive G-protein, but not to adenylate cyclase or dihydropyridinesensitive Ca2+-channels. Acta Physiol. Scand. 134 (1988) 119-126
39. Dunwiddie T.V. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21 (1980) 541-548
40. Dunwiddie T.V., and Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268 (1994) 537-545
41. Dunwiddie T.V., and Fredholm B.B. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J. Pharmacol. Exp. Ther. 249 (1989) 31-37
42. Dunwiddie T.V., and Haas H.L. Adenosine increases synaptic facilitation in the in vitro rat hippocampus: Evidence for a presynaptic site of action. J. Physiol. (London) 369 (1985) 365-377
43. Dunwiddie T.V., and Hoffer B.J. Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br. J. Pharmacol. 69 (1980) 59-68
44. Dunwiddie T.V., and Miller K.K. Effects of adenosine and cadmium on presynaptic fiber spikes in the CA1 region of rat hippocampus in vitro. Neuropharmacology 32 (1993) 1061-1068
45. Dunwiddie T.V., Hoffer B.J., and Fredholm B.B. Alkylxanthines elevate hippocampal excitability: Evidence for a role of endogenous adenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 316 (1981) 326-330
46. Dunwiddie T.V., Diao L., Kim H.O., and Jacobson K.A. Activation of hippocampal adenosine A3 receptors produces a heterologous desensitization of A, receptor mediated responses in rat hippocampus. J. Neurosci. 17 (1997) 607-614
47. Ebstein R.P., and Daly J.W. Release of norepinephrine and dopamine from brain vesicular preparations: Effects of adenosine analogs. Cell. Mol. Neurobiol. 2 (1982) 193-204
48. Fastbom J., Pazos A., and Palacios J.M. The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22 (1987) 813-826
49. Ferre S., von Euler G., Johansson B., Fredholm B.B., and Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7238-7241
50. Feuerstein T.J., Hertting G., and Jackisch R. Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur. J. Pharmacol. 107 (1985) 233-242
51. Fiebich B.L., Biber K., Gyufko K., Berger R., Bauer J., and van Calker D. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem. 66 (1996) 1426-1431
52. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., and Reppert S.M. Molecular cloning of the rat A2 adenosine receptor: Selective co-expression with D2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res. 14 (1992) 186-195
53. Fowler J.C. Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res. 490 (1989) 378-384
54. Fozard J.R., Pfannkuche H.J., and Schuurman H.J. Mast cell degranulation following adenosine At receptor activation in rats. Eur. J. Pharmacol. 298 (1996) 293-297
55. Franco R., Canela E.I., and Bozal J. Heterogeneous localization of some purine enzymes in subcellular fraction of rat brain and cerebellum. Neurochem. Res. 11 (1986) 423-435
56. Fredholm B.B. Differential sensitivity to blockade by 4-aminopyridine of presynaptic receptors regulating [3H]acetylcholine release from rat hippocampus. J. Neurochem. 54 (1990) 1386-1390
57. Fredholm B.B., and Altiok N. Adenosine A2B receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells. Neurochem. Int. 25 (1994) 99-102
58. Fredholm B.B., Fried G., and Hedqvist P. Origin of adenosine released from rat vas deferens by nerve stimulation. Eur. J. Pharmacol. 79 (1982) 233-243
59. Fredholm B.B., Jonzon B., and Lindgren E. Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue. Acta Physiol. Scand. Suppl. 515 (1983) 7-10
60. Fredholm B.B., Dunwiddie T.V., Bergman B., and Lindström K. Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res. 295 (1984) 127-136
61. Fredholm B.B., Proctor W.R., Van der Ploeg I., and Dunwiddie T.V. In vivo pertussis toxin treatment attenuates some, but not all, adenosine A, effects in slices of the rat hippocampus. Eur. J. Pharmacol. 172 (1989) 249-262
62. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., and Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46 (1994) 143-156
63. Freissmuth M., Schutz W., and Linder M.E. Interactions of the bovine brain Ar adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J. Biol. Chem. 266 (1991) 17778-17783
64. Geiger J.D., and Fyda D. Adenosine transport in the CNS. In: Stone T.W. (Ed). "Adenoosine in the Nervous System" (1991), Academic Press 1-23
65. San Diego C., Geiger A., and Nagy J.D.J.I. Distribution of adenosine deaminase activity in rat brain and spinal cord. J. Neurosci. 6 (1986) 2707-2714
66. Gerber U., Greene R.W., Haas H.L., and Stevens D.R. Characterization of inhibition mediated by adenosine in the hippocampus of the rat in vitro. J. Physiol (London) 417 (1989) 567-578
67. Gereau R.W., and Conn IV P.J. Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron 12 (1994) 1121-1129
68. Glass M., Faull R.L.M., Bullock J.Y., Jansen K., Mee E.W., Walker E.B., Synek B.J.L., and Dragunow M. Loss of A, adenosine receptors in human temporal lobe epilepsy. Brain Res. 710 (1996) 56-68
69. Gottesman M.M., and Pastan I. The multidrug transporter, a double-edged sword (review). J. Biol. Chem. 263 (1988) 12163-12166
70. Gribkoff V.K., Bauman L.A., and VanderMaelen C.P. The adenosine antagonist 8-cyclopentyltheophylline reduces the depression of hippocampal neuronal responses during hypoxia. Brain Res. 512 (1990) 353-357
71. Grover L.M., and Teyler T.J. Role of adenosine in heterosynaptiC., posttetanic depression in area CA1 of hippocampus. Neurosci. Lett. 154 (1993) 39-42
72. Gu J.G., Foga I.O., Parkinson F.E., and Geiger J.D. Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations. J. Neurochem. 64 (1995) 2105-2110
73. Harms H.H., Wardeh G., and Mulder A.H. Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. Eur. J. Pharmacol. 49 (1978) 305-308
74. Harms H.H., Wardeh G., and Mulder A.H. Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus stria-tum. Neuropharmacology 18 (1979) 577-580
75. Haulica I., Ababei L., Branisteanu D., and Topoliceanu F. Preliminary data on the possible hypnogenic role of adenosine. J. Neurochem. 21 (1973) 1019-1020
76. Headley P.M., and O'Shaughnessy C.T. The use of cyclic AMP efflux studies in attempts to determine the effects of morphine on cyclic AMP formation in striatal slices. Neuropharmacology 25 (1986) 919-922
77. Hellewell P.G., and Pearson J.D. Metabolism of circulating adenosine by the porcine isolated perfused lung. Circ. Res. 53 (1983) 1-7
78. Henderson G.B., and Strauss B.P. Evidence for cAMP and cholate extrusion in C6 rat glioma cells by a common anion efflux pump. J. Biol. Chem. 266 (1991) 1641-1645
79. Heurteaux C., Lauritzen I., Widmann C., and Lazdunski M. Essential role of adenosine, adenosine A1 receptors and ATP-sensitive K + channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Set. U.S.A. 92 (1995) 4666-4670
80. Hoehn K., and White T.D. Role of excitatory amino acid receptors in K + - and glutamate-evoked release of endogenous adenosine from rat cortical slices. J. Neurochem. 54 (1990) 256-265
81. Hoehn K., and White T.D. Glutamate-evoked release of endogenous adenosine from rat cortical synaptosomes is mediated by glutamate uptake and not by receptors. J. Neurochem. 54 (1990) 1716-1724
82. Hoehn K., and White T.D. N-Methyl-D-Aspartate, Kainate and Quisqualate release endogenous adenosine from rat cortical slices. Neuroscience 39 (1993) 441-450
83. Hoehn K., Craig C.G., and White T.D. A comparison of N-methyl-D-aspartate-evoked release of adenosine and [3H]-norepinephrine from rat cortical slices. J. Pharmacol. Exp. Ther. 255 (1990) 174-181
84. Holgate S.T., Lewis R.A., and Austen K.F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: Agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 6800-6804
85. Hunt J.M., Redman R.S., and Silinsky E.M. Reduction by intracellular calcium chelation of acetylcholine secretion without occluding the effects of adenosine at frog motor nerve endings. Br. J. Pharmacol. 111 (1994) 753-758
86. Jackisch R., Stnttmatter H., Kasakov L., and Hertting G. Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedeberg's Arch. Pharmacol. 327 (1984) 319-325
87. Jacobson K.A., Nikodijevic O., Shi D., Gallo-Rodriguez C., Olah M.E., Stiles G.L., and Daly J.W. A role for central Aradenosine receptors. Mediation of behavioral depressant effects. FEBS Lett. 336 (1993) 57-60
88. James S., and Richardson P.J. Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J. Neurochem. 60 (1993) 219-227
89. Jin S., Johansson B., and Fredholm B.B. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267 (1993) 801-808
90. Jockers R., Linder M.E., Hohenegger M., Nanoff C., Bertin B., Strosberg A.D., Marullo S., and Freissmuth M. Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. J. Biol. Chem. 269 (1994) 32077-32084
91. Johansson B., and Fredholm B.B. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography. Neuro-pharmacology 34 (1995) 393-403
92. Johansson B., Georgiev V., Parkinson F.E., and Fredholm B.B. The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol. 247 (1993) 103-110
93. Jonzon B., and Fredholm B.B. Release of purines, noradrenaline and GABA from rat hippocampal slices by field stimulation. J. Neurochem. 44 (1985) 217-224
94. Katims J.J., Annau Z., and Snyder S.H. Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J. Pharmacol. Exp, Ther. 227 (1983) 167-173
95. Krupinski J., Coussen F., Bakalyar H.A., Tang W.-J., Feinstein P.G., Orth K., Slaughter C., Reed R.R., and Gilman A.G. Adenylyl cyclase amino acid sequence: Possible channel- or transporter-like structure. Science 244 (1989) 1558-1564
96. Kuroda Y. Physiological roles of adenosine derivatives which are released during neurotransmission in mammalian brain. J. Physiol. (Paris) 74 (1978) 463-470
97. Lambert N.A., and Teyler T.J. Adenosine selectively depresses excitatory synaptic transmission in area CA1 of the rat hippocampus. Neurosci. Lett. 122 (1991) 50-52
98. Latini S., Corsi C., Pedata F., and Pepeu G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem. Int. 27 (1995) 239-244
99. Lee C.W., and Jarvis S.M. Kinetic and inhibitor specificity of adenosine transport in guinea pig cerebral cortical synaptosomes: Evidence for two nucleoside transporters. Neurochem. Int. 12 (1988) 483-492
100. Li Y.O., and Fredholm B.B. Adenosine analogues stimulate cyclic AMP formation in rabbit cerebral microvessels via adenosine A2-receptors. Acta Physiol. Scand. 124 (1985) 253-259
101. Lin Y., and Phillis J.W. Characterization of the depression of rat cerebral cortical neurons by selective adenosine agonists. Brain Res. 540 (1991) 307-310
102. Linden J. Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15 (1994) 298-306
103. Lipton P., and Whittingham T.S. Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in the in vitro Guinea-pig hippocampus. J. Physiol. (London) 325 (1982) 51-65
104. Lloyd H.G.E., and Fredholm B.B. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int. 26 (1995) 387-395
105. Lloyd H.G.E., Lindstrom K., and Fredholm B.B. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 23 (1993) 173-185
106. Lupica C.R., Cass W.A., Zahniser N.R., and Dunwiddie T.V. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252 (1990) 1134-1141
107. Lupica C.R., Proctor W.R., and Dunwiddie T.V. Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: Analysis of unitary EPSP variance measured by whole-cell recording. J. Neurosci. 12 (1992) 3753-3764
108. Luthin D.R., and Linden J. Comparison of A4 and A2a, binding sites in striatum and COS cells transfected with adenosine A2a receptors. J. Pharmacol. Exp. Ther. 272 (1995) 511-518
109. MacDonald R.L., Skerritt J.H., and Werz M.A. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture. J. Physiol. (London) 370 (1986) 75-90
110. Manzoni O.J., Manabe T., and Nicoll R.A. Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265 (1994) 2098-2101
111. Mayfield R.D., Suzuki F., and Zahniser N.R. Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J. Neurochem. 60 (1993) 2334-2337
112. Mayfield R.D., Larson G., Orona R.A., and Zahniser N.R. Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: Evidence for an A2a/D2 receptor interaction in globus pallidus. Synapse 22 (1996) 132-138
113. McIlwain H., and Poll J.D. Interaction between adenosine generated endogenously in neocortical tissues and homocysteine and its thiolactone. Neurochem. Int. 7 (1985) 103-110
114. Mcllwain H., and Poll J.D. Adenosine in cerebral homeostatic role: Appraisal through actions of homocysteine, colchicine and dipyridamole. J. Neurobiol. 17 (1986) 39-49
115. Meghji P., Middleton K.M., and Newby A.C. Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. Biochem. J. 249 (1988) 695-703
116. Meghji P., Turtle J.B., and Rubio R. Adenosine formation and release by embryonic chick neurons and glia in cell culture. J. Neurochem. 53 (1989) 1852-1860
117. Meyerhof W., Muller-Brechlin R., and Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284 (1991) 155-160
118. Michaelis M.L., Michaelis E.K., and Myers S.L. Adenosine modulation of synaptosomal dopamine release. Life Sci. 24 (1979) 2083-2092
119. Mitchell J.B., Lupica C.R., and Dunwiddie T.V. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13 (1993) 3439-3447
120. Mogul D.J., Adams M.E., and Fox A.P. Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons. Neuron 10 (1993) 327-334
121. Mons N., and Cooper D.M.F. Adenylate cyclases: Critical foci in neuronal signaling. Trends Neurosci. 18 (1995) 536-542
122. Montero J.M., and Fes J.B. Purification and characterization of bovine brain 5′-nucleotidase. J. Neurochem. 39 (1982) 982-989
123. Mori A., Shindou T., Ichimura M., Nonaka H., and Kase H. The role of adenosine A,., receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci. 16 (1996) 605-611
124. Mynlieff M., and Beam K.G. Adenosine acting at an A, receptor decreases N-type calcium current in mouse motoneurons. J. Neurosci. 14 (1994) 3628-3634
125. Nagy J.I., Geiger J.D., and Daddona P.E. Adenosine uptake sites in rat brain: Identification using [3H]nitrobenzylthioinosine and co-localization with adenosine deaminase. Neurosci. Lett. 55 (1985) 47-53
126. Nagy J.I., Geiger J.D., and Staines W.A. Adenosine deaminase and purinergic neuroregulation. Neurochem. Int 16 (1990) 211-221
127. Newby A.C. Role of adenosine deaminase, ecto-(5′-nucleotidase) and ecto-(non-specific phosphatase) in cyanide-induced adenosine monophosphate catabolism in rat polymorphonuclear leucocytes. Biochem. J. 186 (1980) 907-918
128. Newby A.C. Adenosine and the concept of "retaliatory metabolites.". Trends Biochem. Sci. 9 (1984) 42-44
129. Newby A.C. How does dipyridamole elevate extracellular adenosine concentration. Biochem. J. 237 (1986) 845-851
130. Newby A.C. The pigeon heart 5′-nucleotidase responsible for ischaemia-induced adenosine formation. Biochem. J. 253 (1988) 123-130
131. Nicholson D., White T.D., and Sawynok J. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes. Can. J. Physiol. Pharmacol. 69 (1991) 877-885
132. Pak M.A., Haas H.L., Decking U.K., and Schrader J. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 33 (1994) 1049-1053
133. Palmer T.M., and Stiles G.L. Adenosine receptors. Neuropharmacology 34 (1995) 683-694
134. Palmer T.M., Gettys T.W., and Stiles G.L. Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor. J. Biol. Chem. 270 (1995) 16895-16902
135. Palmer T.M., Benovič J.L., and Stiles G.L. Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor-Evidence for a G-protein-coupled receptor kinase-mediated mechanism. J. Biol. Chem. 270 (1995) 29607-29613
136. Parkinson F.E., and Fredholm B.B. Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990) 85-89
137. Patel B.T., and Tudball N. Localization of S-adenosylhomocysteine hydrolase and adenosine deaminase immunoreactivities in rat brain. Brain Res. 370 (1986) 250-264
138. Pearson J.D. Ectonucleotidases: Measurement of activities and use of inhibitors. Methods Pharmacol. 6 (1985) 83-108
139. Pedata F., Latini S., Pugliese A.M., and Pepeu G. Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neurochem. 61 (1993) 284-289
140. Phillis J.W., and Wu P.H. The role of adenosine and its nucleotides in central synaptic transmission. Prog. Neurobiol. 16 (1981) 187-239
141. Phillis J.W., Edström J.P., Kostopoulos G.K., and Kirkpatrick J.R. Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex. Can. J. Physiol. Pharmacol. 57 (1979) 1289-1312
142. Phillis J.W., Walter G.A., O'Regan M.H., and Stair R.E. Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J. Cereb. Blood Flow Metab. 7 (1987) 679-686
143. Phillis J.W., O'Regan M.H., and Walter G.A. Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex. Brain Res. 481 (1989) 309-316
144. Plagemann P.G., and Wohlhueter R.M. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim. Biophys. Acta 773 (1984) 39-52
145. Porter J.T., and McCarthy K.D. Adenosine receptors modulate [Ca2+]i in hippocampal astrocytes in situ. J. Neurochem. 65 (1995) 1515-1523
146. Potter P., and White T.D. Release of adenosine 5′-triphosphate from synaptosomes from different regions of rat brain. Neuroscience 5 (1980) 1351-1356
147. Pull I., and Mcllwain H. Adenine derivatives as neurohumoral agents in the brain. Biochem. J. 130 (1972) 975-981
148. Rainnie D.G., Grunze H.C.R., McCarley R.W., and Greene R.W. Adenosine inhibition of mesopontine cholinergic neurons: Implications for EEG arousal. Science 263 (1994) 689-692
149. Regenold J.T., Haas H.L., and Illes P. Effects of purinoceptor agonists on electrophys-iological properties of rat mesencephalic trigeminal neurones in vitro. Neurosci. Lett. 92 (1988) 347-350
150. Ribeiro J.A., and Sebastiao A.M. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J. Physiol. (London) 384 (1987) 571-585
151. Richardson P.J., and Brown S.J. ATP release from affinity-purified rat cholinergic nerve terminals. J. Neurochem. 48 (1987) 622-630
152. Richardson P.J., Brown S.J., Bailyes E.M., and Luzio J.P. Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses. Nature (London) 327 (1987) 232-234
153. Rosenberg P.A. Functional significance of cyclic AMP secretion in cerebral cortex (review). Brain Res. Bull. 29 (1992) 315-318
154. Rosenberg P.A., and Dichter M.A. Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J. Neurosci. 9 (1989) 2654-2663
155. Rosenberg P.A., Knowles R., Knowles K.P., and Li Y. Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci. 14 (1994) 2953-2965
156. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., and Firestein G.S. Inhibition of TNF-a expression by adenosine-Role of A, adenosine receptors. J. Immunol. 156 (1996) 3435-3442
157. Sanderson G., and Scholfield C.N. Effects of adenosine uptake blockers and adenosine on evoked potentials of guinea-pig olfactory cortex. Pfluegers Arch. 406 (1986) 25-30
158. Sattin A., and Rall T.W. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol. 6 (1970) 13-23
159. Scanziani M., Capogna M., Gahwiler B.H., and Thompson S.M. Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron 9 (1992) 919-927
160. Schiffmann S.N., Libert F., Vassart G., Dumont J.E., and Vanderhaeghen J.J. A cloned G protein-coupled protein with a distribution restricted to striatal medium-sized neurons. Possible relationship with D1 dopamine receptor. Brain Res. 519 (1990) 333-337
161. Scholfield C.N., and Steel L. Presynaptic K-channel blockade counteracts the depressant effect of adenosine in olfactory cortex. Neuroscience 24 (1989) 81-91
162. Scholz K.P., and Miller R.J. Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron 8 (1992) 1139-1150
163. Schrader J., Wahl M., Kuschinsky W., and Kreutzberg G.W. Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure. Pfluegers Arch. 387 (1980) 245-251
164. Schubert P., Heinemann U., and Lee K.S. Differential effect of adenosine on pre-and postsynaptic calcium fluxes. Brain Res. 376 (1986) 382-386
165. Schwabe U., and Trost T. Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine. Naunyn Schmiedeberg's Arch. Pharmacol. 313 (1980) 179-187
166. Sebastiao A.M., and Ribeiro J.A. Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138 (1992) 41-44
167. Segal M. Intracellular analysis of a postsynaptic action of adenosine in the rat hippocampus. Eur.J. Pharmacol. 79 (1982) 193-199
168. Shimizu H., Creveling C.R., and Daly J. Stimulated formation of adenosine 3′,5′-cyclic phosphate in cerebral cortex: Synergism between electrical activity and biogenic amines. Proc. Natl. Acad. Sci. U.S.A. 65 (1970) 1033-1040
169. Silinsky E.M. On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings. J. Physiol. (London) 346 (1984) 243-256
170. Silinsky E.M., and Hubbard J.I. Release of ATP from rat motor nerve terminals. Nature (London) 243 (1973) 404-405
171. Silinsky E.M., and Solsona C.S. Calcium currents at motor nerve endings: Absence of effects of adenosine receptor agonists in the frog. J. Physiol. (London) 457 (1992) 315-328
172. Skladanowski A.C., Sala G.B., and Newby A.C. Inhibition of IMP-specific cytosolic 5′-nucleotidase and adenosine formation in rat polymorphonuclear leucocytes by 5′-deoxy-5′- isobutylthio derivatives of adenosine and inosine. Biochem. J. 262 (1989) 203-208
173. Smith D.O. Sources of adenosine released during neuromuscular transmission in the rat. J. Physiol. (London) 432 (1991) 343-354
174. Snyder S.H., Katims J.J., Annau Z., Bruns R.F., and Daly J.W. Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 3260-3264
175. Stehle J.H., Rivkees S.A., Lee J.J., Weaver D.R., Deeds J.D., and Reppert S.M. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol. Endocrinol. 6 (1992) 384-393
176. Stone E.A., and John S.M. In vivo measurement of extracellular cyclic AMP in the brain: Use in studies of beta-adrenoceptor function in nonanesthetized rats. J. Neurochem. 55 (1990) 1942-1949
177. Stoof J.C., and Kebabian J.W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature (London) 294 (1981) 366-368
178. Sweeney M.I., White T.D., and Sawynok J. 5-Hydroxytryptamine releases adenosine from primary afferent nerve terminals in the spinal cord. Brain Res. 462 (1988) 346-349
179. Sweeney M.I., White T.D., and Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a dipyridamole-sensitive carrier. J. Neurochem. 52 (1989) S99B (abstr.)
180. Sweeney M.I., White T.D., and Sawynok J. 5-Hydroxytryptamine releases adenosine and cyclic AMP from primary afferent nerve terminals in the spinal cord in vivo. Brain Res 528 (1990) 55-61
181. Sweeney M.I., White T.D., and Sawynok J. Intracerebroventricular morphine releases adenosine and adenosine 3′,5′-cyclic monophosphate from the spinal cord via a serotonergic mechanism. J. Pharmacol. Exp. Ther. 259 (1991) 1013-1018
182. Terrian D.M., Hernandez P.G., Rea M.A., and Peters R.I. ATP release, adenosine formation and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes. J. Neurochem. 53 (1989) 1390-1399
183. Thompson S.M., Haas H.L., and Gahwiler B.H. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J. Physiol. (London) 451 (1992) 347-363
184. Thompson W.J. Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function (review). Pharmacol. Ther. 51 (1991) 13-33
185. Truong V.L., Collinson A.R., and Lowenstein J.M. 5′-Nucleotidases in rat heart. Evidence for the occurrence of two soluble enzymes with different substrate specificities. Biochem. J. 253 (1988) 117-121
186. Trussell L.O., and Jackson M.B. Dependence of an adenosine-activated potassium current on a GTP-binding protein in mammalian central neurons. J. Neurosci. 7 (1987) 3306-3316
187. Ueland P.M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase (review). Pharmacol. Rev. 34 (1982) 223-253
188. Ulrich D., and Huguenard J.R. Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity. Neuron 15 (1995) 909-918
189. Umemiya M., and Berger A.J. Activation of adenosine A1 and A2 receptors differentially modulates calcium channels and glycinergic synaptic transmission in rat brainstem. Neuron 13 (1994) 1439-1446
190. van Calker D., Muller M., and Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33 (1979) 999-1005
191. Van den Berghe G., van Pottelsberghe C., and Hers H.G. A kinetic study of the soluble 5′-nucleotidase of rat liver. Biochem. J. 162 (1977) 611-616
192. Von Lubitz D.K., Lin J.E.R.C.S., Melman N., Ji X.D., Carter M.F., and Jacobson K.A. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmacol. 256 (1994) 161-167
193. Von Lubitz D.K., Lin J.E.R.C.S., Popik P., Carter M.F., and Jacobson K.A. Adenosine A, receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263 (1994) 59-67
194. Wan W., Sutherland G.R., and Geiger J.D. Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: Evidence for multiple affinity sites. J. Neurocbem. 55 (1990) 1763-1771
195. Wieraszko A., Goldsmith G., and Seyfried T.N. Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res. 485 (1989) 244-250
196. Worku Y., and Newby A.C. The mechanism of adenosine production in rat polymor-phonuclear leucocytes. Biochem. J. 214 (1983) 325-330
197. Wu L.G., and Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12 (1994) 1139-1148
198. Wu L.G., and Saggau P. Presynaptic calcium is increased during normal synaptic transmission and paired-pulse facilitation, but not in long-term potentiation in area CA1 of hippocampus. J. Neurosci. 14 (1994) 645-654
199. Wu P.H., and Phillis J.W. Distribution and release of adenosine triphosphate in rat brain. Neurochem. Res. 3 (1978) 563-571
200. Wu P.H., Barraco R.A., and Phillis J.W. Further studies on the inhibiton of adensoine uptake into rat brain synaptosomes by adenosine derivatives and methylxanthines. Gen. Pharmacol. 15 (1984) 251-254
201. Wu Y., Mercuri N.B., and Johnson S.W. Presynaptic inhibition of gamma-aminobu-tyric acid B-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 273 (1995) 576-581
202. Yawo H., and Chuhma N. Preferential inhibition of conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature (London) 365 (1993) 256-258
203. Yoneda K., and Okada Y. Effects of anoxia and recovery on the neurotransmission and level of high-energy phosphates in thin hippocampal slices from the guinea-pig. Neuroscience 28 (1989) 401-407
204. Yoon K.W., and Rothman S.M. Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J. Neurosci. 11 (1991) 1375-1380
205. Zetterstrom T., and Fillenz M. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 180 (1990) 137-143
206. Zetterström T., Vernet L., Ungerstedt U., Tossman U., and Jonzon B. Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci. Lett. 29 (1982) 111-115
207. Zgombick J.M., Beck S.G., Mahle C.D., Craddock-Royal B., and Maayani S. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptaminelA receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies. Mol. Pharmacol. 35 (1989) 484-494
208. Zhang G., Franklin P.H., and Murray T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264 (1993) 1415-1424
209. Zhou Q., Li C., Olah M.E., Johnson R.A., and Stiles G.L. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7432-7436
210. Zimmermann H. 5′-Nucleotidase: Molecular structure and functional aspects. Biochem. J. 285 (1992) 345-365
211. Zimmermann H., Dowdall M.J., and Lane D.A. Purine salvage at the cholinergic nerve endings of the torpedo electric organ: The central role of adenosine. Neuroscience 4 (1979) 979-993